Dilemma of antithrombotic therapy in anticoagulated atrial fibrillation patients squeezed between thrombosis and bleeding events: A single-centre experience

Europace

Volumn 11, Issue 7, 2009, Pages 957-960

  Halbfass, Philipp ^a   Janko, Sabine ^a   Dorwarth, Uwe ^a   Riess, Gotthard ^a   Antoni, Diethmar ^a   Hoffmann, Ellen ^a  

^a Heart Center Bogenhausen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; COUMARIN; PHENPROCOUMON;

ADULT; AGED; ARTICLE; BLEEDING; COMORBIDITY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RESTENOSIS; RISK BENEFIT ANALYSIS; STENT THROMBOSIS; STROKE; THROMBOEMBOLISM; THROMBOSIS; THROMBOSIS PREVENTION; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 67650866686     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup131     Document Type: Article

References (8)

1. Lip GY, Varma C. Anticoagulation plus aspirin following acute myocardial infarction. Thromb Res 2006;118:429-32.
2. Manzano-Fernandez S, Pastor FJ, Marin F, Cambronero F, Caro C, Pascual-Figal DA et al. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest 2008;134:559-67.
3. Rubboli A, Halperin JL, Airaksinen KEJ, Buerke M, Eeckhout E, Freedman SB et al. Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. Ann Med 2008;40:428- 36.
4. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. Circulation 2006;114:257-354.
5. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005;3: 692-4.
6. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115:2344-51.
7. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC et al. Outcome parameters for trials in atrial fibrillation. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007;9:1006-23.
8. Sarafoff N, Ndrepepa G, Mehilli J, Dörrler K, Schulz S, Iijima R et al. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation. J Intern Med 2008;264:472-80